New Metastatic Human Breast Carcinoma Xenograft Line
Author Information
Author(s): RR Mehta, JM Graves, A Shilkaitis, TK Das Gupta
Primary Institution: University of Illinois at Chicago
Hypothesis
Can a new human breast carcinoma xenograft line be developed that shows high tumorigenicity and metastatic potential?
Conclusion
The UISO-BCA-NMT-18 xenograft line demonstrates 100% tumorigenicity and 80-100% lung metastasis, making it a valuable model for breast cancer research.
Supporting Evidence
- The xenograft line shows 100% tumorigenicity in athymic mice.
- 80-100% of the xenografts developed lung metastasis.
- The xenograft is responsive to exogenous estrogen.
- Immunohistochemical analysis showed intense staining for mutant p53 and high expression of U-PA, PAI, and u-PAR.
Takeaway
Scientists created a new type of breast cancer model that grows tumors and spreads in mice, which can help them study how breast cancer works.
Methodology
The study involved creating a xenograft from a primary human breast carcinoma using enzymatic digestion and Matrigel, followed by serial transplantation in athymic mice.
Limitations
The study primarily focused on a single xenograft line and its characteristics, which may not represent all breast cancer types.
Participant Demographics
The original tumor was obtained from a 41-year-old woman with primary breast carcinoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website